Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Despite the end of the pandemic, coronavirus disease 2019 (COVID-19) remains a major
public health concern. The first waves of the virus led to a better understanding of its …

As the world progressively recovers from the acute stages of the coronavirus disease 2019
(COVID-19) pandemic, we may be facing new challenges regarding the long-term …

Zusammenfassung Hintergrund Pulmonale Manifestationen sind sehr häufige
Folgeerscheinungen nach einer Severe-acute-respiratory-syndrome-coronavirus-type-2 …

Pulmonary arterial hypertension (PAH) is common in severe coronavirus disease 2019
(COVID-19) and worsens the prognosis. Sildenafil, a phosphodiesterase-5 inhibitor, is …

Background: We herein report two cases of sudden onset symptomatic pulmonary
hypertension after coronavirus disease 2019 (COVID-19) vaccination. Case Summary …

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by widespread
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused …

Minoritized racial and ethnic groups suffer disproportionately from the incidence and
morbidity of pulmonary hypertension (PH), as well as its associated cardiovascular …

Background/Objectives: Pulmonary hypertension (PH) often accompanies chronic lung
diseases. Several chronic lung diseases with PH portends unfavorable outcomes. We …

Abstract Coronavirus disease 2019 (COVID-19) is a disease characterized by diverse
clinical manifestations, the severity of which can vary from asymptomatic to extremely …